Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Transplantation
|
February 14, 2007
Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients
Henrik Ekberg, Lauri Kyllönen, Søren Madsen, et al.
Transplantation
|
November 9, 2007
Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists
Henrik Ekberg, Lauri Kyllönen, Søren Madsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
June 7, 2003
[Discouraging about drug therapy]
Atle Skattebøl, Gry Bratten, Dag Solbu, et al.
Biomarkers in Medicine
|
February 14, 2014
Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels
Finn Gustafsson, Einar Gude, Vilborg Sigurdardottir, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 1, 2009
Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study
Martin Iversen, Folke Nilsson, Jorma Sipponen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
September 2, 2014
Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
Lars Mjörnstedt, Søren Schwartz Sørensen, Bengt von Zur Mühlen, et al.
Transplantation
|
March 21, 2019
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study
Finn Gustafsson, Arne K Andreassen, Bert Andersson, et al.
Clinical Transplantation
|
June 23, 2017
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
Anne Relbo Authen, Ingelin Grov, Kristjan Karason, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
April 13, 2016
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
Lars Gullestad, Hans Eiskjaer, Finn Gustafsson, et al.
Circulation. Heart Failure
|
October 26, 2018
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
Satish Arora, Arne K Andreassen, Kristjan Karason, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Transplantation
|
February 14, 2007
Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients
Henrik Ekberg, Lauri Kyllönen, Søren Madsen, et al.
Transplantation
|
November 9, 2007
Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists
Henrik Ekberg, Lauri Kyllönen, Søren Madsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
June 7, 2003
[Discouraging about drug therapy]
Atle Skattebøl, Gry Bratten, Dag Solbu, et al.
Biomarkers in Medicine
|
February 14, 2014
Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels
Finn Gustafsson, Einar Gude, Vilborg Sigurdardottir, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 1, 2009
Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study
Martin Iversen, Folke Nilsson, Jorma Sipponen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
September 2, 2014
Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
Lars Mjörnstedt, Søren Schwartz Sørensen, Bengt von Zur Mühlen, et al.
Transplantation
|
March 21, 2019
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study
Finn Gustafsson, Arne K Andreassen, Bert Andersson, et al.
Clinical Transplantation
|
June 23, 2017
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
Anne Relbo Authen, Ingelin Grov, Kristjan Karason, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
April 13, 2016
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
Lars Gullestad, Hans Eiskjaer, Finn Gustafsson, et al.
Circulation. Heart Failure
|
October 26, 2018
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
Satish Arora, Arne K Andreassen, Kristjan Karason, et al.
Page
of 2